SCHEMBL698730

SCHEMBL698730

Cc1ccc(F)cc1CO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.41
SLC6A4 P31645 4/20 0.39
HTR2A P28223 1/20 0.39
KCNH2 Q12809 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
S1PR1 P21453 1/20 0.38
SLC6A2 P23975 3/20 0.36
HPGD P15428 1/20 0.36
MEP1B Q16820 1/20 0.36
P2RX7 Q99572 1/20 0.35
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLC6A3 Q01959 2/20 0.35
NR3C1 P04150 2/20 0.35
PGR P06401 1/20 0.35
NR3C2 P08235 1/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7336718 0.84 HPGD (0.42) SHBGSLC6A4PTGS1PTGS2HPGD
SCHEMBL18959855 0.83 PTGS1 (0.40) SLC6A4HTR2AKCNH2PTGS1PTGS2
SCHEMBL11116185 0.82 SLC6A4 (0.39) SLC6A4HTR2AKCNH2PTGS1PTGS2
SCHEMBL30303044 0.82 MAPK14 (0.40) SHBGPTGS1PTGS2P2RX7NR3C2
SCHEMBL2476555 0.82 MAPK14 (0.40) SHBGPTGS1PTGS2P2RX7NR3C2
SCHEMBL17188320 0.79 ALDH1A1 (0.40) SLC6A4HTR2AKCNH2PTGS1PTGS2
SCHEMBL16385035 0.79 SLC6A4 (0.40) SLC6A4HTR2AKCNH2PTGS1PTGS2
SCHEMBL8240380 0.79 SLC6A4 (0.40) SLC6A4HTR2AKCNH2SLC6A2MEP1B
SCHEMBL31085527 0.78 IDO1 (0.40) SLC6A4SLC6A2SMN1; SMN2
SCHEMBL3309883 0.78 IDO1 (0.40) SLC6A4SLC6A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3547414-B1 LITHIUM ELECTRODE AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2023-09-13 EP claimed
EP-3664213-B1 ELECTROLYTE FOR LITHIUM METAL BATTERY AND LITHIUM METAL BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2023-09-13 EP claimed
US-11495824-B2 Electrolyte for lithium metal battery and lithium metal battery comprising same LG ENERGY SOLUTION, LTD. (KR) 2022-11-08 US claimed
CN-110192294-B Lithium electrode and lithium secondary battery comprising same 株式会社LG新能源 2022-09-20 CN claimed
US-20200203759-A1 ELECTROLYTE FOR LITHIUM METAL BATTERY AND LITHIUM METAL BATTERY COMPRISING SAME LG CHEM, LTD. (KR) 2020-06-25 US claimed
EP-3664213-A2 ELECTROLYTE FOR LITHIUM METAL BATTERY AND LITHIUM METAL BATTERY COMPRISING SAME LG Chem, Ltd. (KR) 2020-06-10 EP claimed
US-20190319272-A1 LITHIUM ELECTRODE AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG CHEM, LTD. (KR) 2019-10-17 US claimed
EP-3547414-A2 LITHIUM ELECTRODE AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG Chem, Ltd. (KR) 2019-10-02 EP claimed
US-9238611-B2 Process for separating aryl carboxylic acids RELIANCE INDUSTRIES LIMITED (IN) 2016-01-19 US claimed
US-20150065748-A1 PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS RELIANCE INDUSTRIES LIMITED (IN) 2015-03-05 US claimed
EP-2831027-A1 A PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS Reliance Industries Limited (IN) 2015-02-04 EP claimed
WO-2013164852-A1 A PROCESS FOR SEPARATING ARYL CARBOXYLIC ACIDS RELIANCE INDUSTRIES LIMITED (IN) 2013-11-07 WO claimed
WO-2023183585-A1 KRAS INHIBITORS ELI LILLY AND COMPANY (US) 2023-09-28 WO disclosed
EP-3547414-B1 LITHIUM ELECTRODE AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2023-09-13 EP disclosed
EP-3664213-B1 ELECTROLYTE FOR LITHIUM METAL BATTERY AND LITHIUM METAL BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2023-09-13 EP disclosed
EP-4194452-A1 AROMATIC COMPOUND AND APPLICATION THEREOF IN ANTITUMOR DRUG Shanghai Zheye Biotechnology Co., Ltd. (CN) 2023-06-14 EP disclosed
US-7186737-B2 Inhibitors of p38 VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-03-06 US disclosed
US-7186737-B2 Inhibitors of p38 VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-03-06 US disclosed
EP-1404335-A1 AMINO NICOTINATE DERIVATIVES AS GLUCOKINASE (GLK) MODULATORS Astrazeneca AB (SE) 2004-04-07 EP disclosed
WO-2003000267-A1 AMINO NICOTINATE DERIVATIVES AS GLUCOKINASE (GLK) MODULATORS ASTRAZENECA AB (SE) 2003-01-03 WO disclosed